Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HEALTH MANAGEMENT CONSULTANTS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.7% 13.1% 8.3% 9.6% 9.0% 8.2% 19.7% 19.7%   Credit score (0-100)   42 19 29 24 27 29 6 6   Credit rating   BBB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   18.1 253 -22.2 -21.9 -16.6 -15.5 0.0 0.0   EBITDA   18.1 253 -22.2 -21.9 -16.6 -15.5 0.0 0.0   EBIT   18.1 253 -22.2 -21.9 -16.6 -15.5 0.0 0.0   Pre-tax profit (PTP)   22.6 231.6 -12.3 329.2 -298.5 -24.9 0.0 0.0   Net earnings   22.6 231.6 -4.0 256.8 -233.5 -19.9 0.0 0.0   Pre-tax profit without non-rec. items   22.6 232 -12.3 329 -299 -24.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,279 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   79.5 311 307 564 330 310 185 185   Interest-bearing liabilities   1,301 1,291 845 795 733 544 0.0 0.0   Balance sheet total (assets)   1,440 1,614 1,165 1,433 1,077 868 185 185   Net Debt   1,224 1,171 -303 -630 -278 -245 -185 -185     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   18.1 253 -22.2 -21.9 -16.6 -15.5 0.0 0.0   Gross profit growth   0.0% 1,291.6% 0.0% 1.4% 23.9% 7.0% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,440 1,614 1,165 1,433 1,077 868 185 185   Balance sheet change%   0.4% 12.1% -27.8% 23.0% -24.8% -19.5% -78.6% 0.0%   Added value   18.1 252.5 -22.2 -21.9 -16.6 -15.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -21 -1,279 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.0% 16.5% 1.5% 26.3% -0.0% -0.2% 0.0% 0.0%   ROI %   3.1% 16.9% 1.5% 27.2% -0.0% -0.2% 0.0% 0.0%   ROE %   33.2% 118.6% -1.3% 59.0% -52.2% -6.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.5% 19.3% 26.4% 39.3% 30.7% 35.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   6,744.4% 463.9% 1,365.3% 2,881.4% 1,670.7% 1,579.6% 0.0% 0.0%   Gearing %   1,637.7% 415.0% 275.2% 140.9% 222.0% 175.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.6% 1.6% 3.1% 1.5% 39.1% 3.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 1.2 1.4 1.6 1.4 1.6 0.0 0.0   Current Ratio   0.2 1.2 1.4 1.6 1.4 1.6 0.0 0.0   Cash and cash equivalent   77.6 119.6 1,147.9 1,424.6 1,011.4 788.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -778.2 280.8 -831.7 -819.5 -672.2 -457.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   18 253 -22 -22 -17 -15 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   18 253 -22 -22 -17 -15 0 0   EBIT / employee   18 253 -22 -22 -17 -15 0 0   Net earnings / employee   23 232 -4 257 -234 -20 0 0